Ivermectin is effective for COVID-19: real-time meta analysis of 50 studies
https://ivmmeta.com/
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Ivermectin shows clinical benefits in mild to moderate Covid-19 – A randomised controlled double-blind, dose-response study in Lagos
Preliminary meta-analysis of randomised trialis of ivermectin to treat SARS-Cov-2 infection
Remdesivir and chloroquine effectivly inhibits the recently emerged novel coronavirus (2019-nCov) in vitro
A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19
